Literature DB >> 31656722

2-Amino-4-(1-piperidine) pyridine exhibits inhibitory effect on colon cancer through suppression of FOXA2 expression.

Jieshu Wang1, Bo Li1, Kun Zhao1, Xinyou Su2.   

Abstract

The present study was aimed to investigate the effect of 2-amino-4-(1-piperidine) pyridine on migration and invasion of colon cancer cells. Treatment of colon cancer cells with 2-amino-4-(1-piperidine) pyridine reduced viability in concentration-based manner. The migration potential of HCT116 and HT29 cells was also suppressed on treatment with 2-amino-4-(1-piperidine) pyridine. In HCT116 and HT29 cells, apoptotic cell proportion was increased significantly by 2-amino-4-(1-piperidine) pyridine treatment. The expression of EMT and Vimentin in HCT116 and HT29 cells was reduced markedly on treatment with 2-amino-4-(1-piperidine) pyridine. The expression of E-cadherin was increased in HCT116 and HT29 cells by 2-amino-4-(1-piperidine) pyridine treatment. Treatment with 2-amino-4-(1-piperidine) pyridine reduced the expression of FOXA2 in HCT116 and HT29 cells. The 2-amino-4-(1-piperidine) pyridine treatment reduced growth of tumor in vivo in mice model. In summary, 2-amino-4-(1-piperidine) pyridine treatment inhibits colon cancer cell proliferation through down-regulation of FOXA2 expression. Therefore, 2-amino-4-(1-piperidine) pyridine can be used for the treatment of colon cancer. © King Abdulaziz City for Science and Technology 2019.

Entities:  

Keywords:  Forkhead box; Malignant; Mesenchymal transition; Metastasis

Year:  2019        PMID: 31656722      PMCID: PMC6778160          DOI: 10.1007/s13205-019-1915-1

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  45 in total

1.  MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.

Authors:  Cong Li; Sumei Lu; Yubin Shi
Journal:  Oncol Rep       Date:  2017-01-16       Impact factor: 3.906

2.  Downregulation of expression of mater genes SOX9, FOXA2, and GATA4 in pancreatic cancer cells stimulated with TGFβ1 epithelial-mesenchymal transition.

Authors:  L G Kondratyeva; A A Sveshnikova; E V Grankina; I P Chernov; M R Kopantseva; E P Kopantzev; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2016-09-07       Impact factor: 0.788

3.  Sedentary work and the risks of colon and rectal cancer by anatomical sub-site in the Canadian census health and environment cohort (CanCHEC).

Authors:  Manisha Pahwa; M Anne Harris; Jill MacLeod; Michael Tjepkema; Paul A Peters; Paul A Demers
Journal:  Cancer Epidemiol       Date:  2017-06-23       Impact factor: 2.984

4.  P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.

Authors:  Sara Laudato; Nitin Patil; Mohammed L Abba; Joerg H Leupold; Axel Benner; Timo Gaiser; Alexander Marx; Heike Allgayer
Journal:  Int J Cancer       Date:  2017-07-24       Impact factor: 7.396

5.  A causal role for E-cadherin in the transition from adenoma to carcinoma.

Authors:  A K Perl; P Wilgenbus; U Dahl; H Semb; G Christofori
Journal:  Nature       Date:  1998-03-12       Impact factor: 49.962

6.  Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers.

Authors:  Hagit Schayek; Yael Laitman; Lior H Katz; Elon Pras; Liat Ries-Levavi; Frida Barak; Eitan Friedman
Journal:  Isr Med Assoc J       Date:  2017-06       Impact factor: 0.892

7.  Stability of the hepatocyte nuclear factor 6 transcription factor requires acetylation by the CREB-binding protein coactivator.

Authors:  Francisco M Rausa; Douglas E Hughes; Robert H Costa
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

8.  Temporal regulation of epithelium formation mediated by FoxA, MKLP1, MgcRacGAP, and PAR-6.

Authors:  Stephen E Von Stetina; Jennifer Liang; Georgios Marnellos; Susan E Mango
Journal:  Mol Biol Cell       Date:  2017-05-24       Impact factor: 4.138

9.  ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.

Authors:  Darina Lazarova; Michael Bordonaro
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

10.  [ARTICLE WITHDRAWN] MicroRNA-539 Inhibits the Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4.

Authors:  Zhili Cao; Xiang Zheng; Lei Cao; Naixin Liang
Journal:  Oncol Res       Date:  2017-06-12       Impact factor: 5.574

View more
  1 in total

Review 1.  Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Sicon Mitra; Uttpal Anand; Niraj Kumar Jha; Mahipal S Shekhawat; Suchismita Chatterjee Saha; Potshangbam Nongdam; Kannan R R Rengasamy; Jarosław Proćków; Abhijit Dey
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.